Applying for CDSCO license for your drug? Make Sure your formulation does not have similar brand name Farhat Nasim9 Nov 2019 4:52 PM ISTNew Delhi: In a bid to curb the irrational practice of using similar names for different drugs that results in utter confusion, the Union Health...
PIL against Health Ministry notifying 8 medical devices as DRUGS, Delhi HC seeks Centre reply Medical Dialogues Bureau30 Sept 2019 5:54 PM ISTIt was submitted that notifying blood monitoring devices, digital thermometers, nebulizers and glucometers as DRUGS will result in a substantial hike...
Stop use of trademark deceptively similar to Glaxo antibiotic Augmentin: Delhi High Court to AFDIL Farhat Nasim29 Jun 2019 11:56 AM ISTThe court's order came on a plea by Glaxo Group Ltd which sought to restrain AFDIL from advertising, marketing or in any manner doing business under...
Lupin gets tentative USFDA nod for generic version of Mirabegron ER tablets Farhat Nasim28 Jun 2019 11:10 AM ISTThe approval by the US Food and Drug Administration (USFDA) is for a generic version of Mirabegron ER tablets of strengths 25 mg and 50 mg, Lupin said...
Sanofi, Google team up to discover better treatments Medical Dialogues Bureau23 Jun 2019 9:05 AM ISTSanofi and Google will use data sets to improve their understanding of key diseases and extract patients' insights and feedback, the companies said in...
Delhi High Court directs RSSB chief Dhillon, family to undertake Singh brothers dues to Daiichi Farhat Nasim11 Jun 2019 3:31 PM ISTNew Delhi: Bringing in a third party, the Delhi High Court has directed Radha Soami Satsang Beas (RSSB) chief Gurinder Singh Dhillon and his family...
Netmeds to add dozen more fulfillment centers in India by 2020 Medical Dialogues Bureau12 May 2019 9:29 AM ISTChennai: Online pharmacy Netmeds.com Thursday said it will add 12 fulfilment centres across the country by 2020 in an effort to facilitate quick...
Washington: Drugmakers will have to reveal medicine prices in TV ads Medical Dialogues Bureau10 May 2019 9:10 AM ISTHealth and Human Services Secretary Alex Azar said the Trump administration has finalized regulations that will require drug companies to disclose...
Glenmark launches SGLT2 Inhibitor Remogliflozin under brand names Remo, Remozen Meghna A Singhania30 April 2019 10:16 AM ISTGlenmark will commercialize Remogliflozin in India under the brand names 'Remo' and 'Remozen'.Mumbai: In a major relief to diabetics, Glenmark...
Using AI to detect mental health disorders likely to be counterproductive Medical Dialogues Bureau30 April 2019 9:00 AM ISTAI-based vocal analytics may allow patients to detect the disease at home by just speaking into a smartphone application, eliminating the need to be...
E-platform M3 acquires majority share in Neuroglia Health Private Limited Garima23 April 2019 9:30 AM ISTNew Delhi: An online platform for medical professionals, M3, Inc. of Japan has announced the acquisition of a majority stake of India based Neuroglia...
All medical devices sold in India to be CDSCO certified: What is Means Meghna A Singhania18 April 2019 2:59 PM ISTOnce this notification comes into effect, the manufacture and sale of all medical devices would have to be certified by the Central Drugs Standard...
